Tsp Capital Management Group, LLC Celldex Therapeutics, Inc. Transaction History
Tsp Capital Management Group, LLC
- $280 Million
- Q1 2025
A detailed history of Tsp Capital Management Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Tsp Capital Management Group, LLC holds 335,977 shares of CLDX stock, worth $7.66 Million. This represents 2.18% of its overall portfolio holdings.
Number of Shares
335,977
Previous 223,343
50.43%
Holding current value
$7.66 Million
Previous $5.64 Million
8.05%
% of portfolio
2.18%
Previous 2.14%
Shares
24 transactions
Others Institutions Holding CLDX
# of Institutions
190Shares Held
69.3MCall Options Held
220KPut Options Held
310K-
Wellington Management Group LLP Boston, MA8.35MShares$191 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.5MShares$148 Million9.94% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$107 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$88.9 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$85.6 Million1.45% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.07B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...